Page 1

CORTEVA ™ agriscience Corteva Reports Third Quarter and Year - to - Date 2021 Results , Affirms Full - Year Guidance WILMINGTON , Del . , November 3 , 2021 - Corteva , Inc. ( NYSE : CTVA ) ( " Corteva " or the " Company " ) today reported financial results for the third quarter and nine months ended September 30 , 2021 . 3Q 2021 Results Overview GAAP vs. 3Q 2020 NON - GAAP vs. 3Q 2020 YTD 2021 Results Overview GAAP vs. YTD 2020 NON - GAAP vs. YTD 2020 Net Sales $ 2.4B + 27 % Organic¹ Sales $ 2.3B + 24 % Net Sales $ 12.2B + 11 % Organic¹ Sales $ 12.0B + 9 % Third Quarter 2021 Highlights • Net Sales for the third quarter 2021 increased 27 % versus prior year , led by Latin America and North America² . Organic¹ sales rose 24 % in the same period , with volume and price gains on continued penetration of new technology and strong execution globally . Crop Protection net sales grew 22 % and organic¹ sales increased 19 % for the third quarter . All regions delivered sales gains during the quarter in the segment . Sales of new products drove volume improvement , led by IsoclastTM insecticide . Price gains reflected strong execution . News Release 3Q 2021 Seed net sales increased 41 % and organic¹ sales grew 37 % compared to the year - ago period . Volume increases were broad - based , led by North America . Price was up 19 % globally , driven by continued strength in Latin America and fewer corn replant units in North America . Income from Cont . Ops ( After Tax ) $ 36M + 109 % Operating EBITDA¹ $ ( 51 ) M + 72 % Income from Cont . Ops ( After Tax ) $ 1.7B + 154 % Operating EBITDA¹ $ 2.31B + 25 % EPS ● $ 0.05 + 110 % Operating EPS¹ $ ( 0.14 ) + 64 % EPS $ 2.23 + 162 % Operating EPS¹ $ 2.06 + 41 % • GAAP income and earnings per share ( EPS ) from continuing operations were $ 36 million and $ 0.05 per share for the third quarter 2021 , respectively . • Volume gains and strong price execution in both segments drove Operating EBITDA¹ improvement of 72 % , as compared to the same period last year . The Company's continued productivity progress in the third quarter partially offset the impact of ongoing raw material cost inflation and other market - driven headwinds . • The Company affirmed previously provided Operating EBITDA¹ guidance³ in the range of $ 2.5 billion and $ 2.6 billion . Corteva increased its net sales guidance to be in the range of $ 15.5 billion and $ 15.7 billion and increased Operating EPS¹ guidance to be in the range of $ 2.05 and $ 2.15 per share . 1. Organic Sales , Operating EPS and Operating EBITDA are non - GAAP measures . See page A - 6 for further discussion . 2. North America is defined as U.S. and Canada . EMEA is defined as Europe , Middle East and Africa . 3. The Company does not provide the most comparable GAAP measure on a forward - looking basis . See page 6 for further discussion . 4. Enlist E3TM soybeans are jointly developed by Corteva Agriscience LLC and MS Technologies TM 5. Launches pending all applicable regulatory reviews and approvals . 6. Shares of the Company's common stock may be repurchased periodically in open - market or private transactions . The actual timing , number and value of shares repurchased under the Company's authorized share repurchase program will be determined by management at its discretion and will depend on a variety of factors including the market price of Corteva common stock , general market and economic conditions , applicable legal requirements and other business considerations . 1